Gainers
- Sharps Compliance Corp. (NASDAQ:SMED) shares jumped 196.1% to close at $8.44 on Tuesday after the company it will be acquired by an affiliate of Aurora Capital Partners for $8.75 per share.
- Canoo Inc. (NASDAQ:GOEV) shares climbed 53.2% to close at $3.63 after Walmart signed a definitive agreement with the company to purchase 4,500 all-electric delivery vehicles, beginning with the Lifestyle Delivery Vehicle, with the option to purchase up to 10,000 units.
- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) jumped 42.2% to close at $6.67 after the company announced positive interim results from a Phase 2 clinical trial evaluating setmelanotide for the treatment of severe obesity and hyperphagia in people living with hypothalamic obesity.
- Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares jumped 39% to close at $11.98. The FDA has removed the clinical hold on Greenwich LifeSciences’ Flamingo-01 Phase 3 trial of GP2, immunotherapy to prevent breast cancer recurrences.
- Regional Health Properties, Inc. (NYSE:RHE) gained 36.9% to close at $3.73.
- China Online Education Group (NYSE:COE) jumped 32.8% to settle at $1.6074. China Online Education Group, last month, reported a first-quarter FY22 revenue decline of 89.7% year-on-year to $9.5 million.
- Histogen Inc. (NASDAQ:HSTO) rose 27.5% to close at $3.76 after gaining around 12% on Monday. The company, last month, announced a 1-for-20 reverse stock split.
- Romeo Power, Inc. (NYSE:RMO) surged 26% to settle at $0.63. Romeo Power highlighted opening of new manufacturing center.
- Lucira Health, Inc. (NASDAQ:LHDX) gained 24.3% to settle at $3.02.
- Aclarion, Inc. (NASDAQ:ACON) jumped 22.9% to close at $1.01.
- Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) climbed 22.6% to close at $3.31. Blue Hat Interactive Entertainment Technology reported a registered direct offering of ordinary shares.
- Kaspien Holdings Inc. (NASDAQ:KSPN) fell 22.5% to close at $5.28 after jumping around 162% on Monday.
- NuCana plc (NASDAQ:NCNA) gained 21.1% to close at $0.9689. Regional Court of Dusseldorf has ruled in favor of NuCana, stating that Gilead Sciences Ireland UC and Gilead Sciences GmbH infringed NuCana's composition of matter claims in European Patent 2955190 through their sales of Sovaldi, Harvoni, Vosevi and Epclusa in Germany.
- Alpha Teknova, Inc. (NASDAQ:TKNO) climbed 21.1% to settle at $9.20. Alpha Teknova recently filed for mixed shelf of up to $225 million.
- SunLink Health Systems, Inc. (NYSE:SSY) rose 20.8% to close at $1.17.
- Eos Energy Enterprises, Inc. (NASDAQ:EOSE) gained 19% to close at $2.13. Eos Energy Enterprises recently announced the signing of two orders with Bridgelink Commodities and a Northeast solar developer totaling 1.1 GWh of energy storage capacity, and said its backlog is now over $460 million.
- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) surged 18.1% to settle at $1.50.
- MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) rose 17.1% to close at $5.00.
- Atara Biotherapeutics, Inc. (NASDAQ:ATRA) gained 17% to close at $8.66.
- Atara Biotherapeutics reported completion of the ATA188 Phase 2 EMBOLD study interim analysis in patients with progressive MS.
- Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) gained 15.7% to close at $3.40.
- Indonesia Energy Corporation Limited (NYSE:INDO) rose 15.6% to close at $6.73 after the company announced it has discovered a potential natural gas bearing reservoir while drilling the Kruh-28 well.
- InMode Ltd. (NASDAQ:INMD) gained 15.5% to close at $26.73 after the company issued Q2 EPS and sales guidance above analyst estimates. The company also raised its FY22 sales guidance above estimates.
- Versus Systems Inc. (NASDAQ:VS) climbed 15.2% to close at $0.5415. Versus Systems, last month, received NASDAQ notification regarding minimum bid price deficiency.
- Herbalife Nutrition Ltd. (NYSE:HLF) rose 15.2% to close at $22.70 after Jefferies upgraded the stock from Hold to Buy.
- Versus Systems Inc. (NASDAQ:VS) jumped 15.2% to close at $0.5415.
- A2Z Smart Technologies Corp. (NASDAQ:AZ) gained 15.2% to settle at $2.88.
- Winc, Inc. (NYSE:WBEV) jumped 15.1% to close at $1.45.
- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) rose 15% to settle at $5.14. Aldeyra Therapeutics achieved the primary endpoints in a crossover clinical trial of 0.25% reproxalap ophthalmic solution, an investigational new drug candidate for dry eye disease.
- Akanda Corp. (NASDAQ:AKAN) gained 14.7% to close at $0.90 after the company announced it will supply Tetra Bio-Pharma with pharmaceutical-grade cannabis for FDA trials of QIXLEEF.
- GreenLight Biosciences Holdings (NASDAQ:GRNA) rose 13.7% to close at $2.32.
- Westport Fuel Systems Inc. (NASDAQ:WPRT) climbed 12.9% to close at $1.14. Westport Fuel Systems was awarded €38 million program to supply LPG fuel systems to a global OEM.
- American Airlines Group Inc. (NASDAQ:AAL) surged 10% to settle at $14.77 after the company said it expects Q2 revenue up 12% from 2019 levels.
- Target Hospitality Corp. (NASDAQ:TH) gained 9.5% to close at $9.93.
- United Airlines Holdings, Inc. (NASDAQ:UAL) rose 8.1% to settle at $38.23. Susquehanna maintained United Airlines Holdings with a Positive and lowered the price target from $60 to $43.
- Carnival Corporation (NYSE:CCL) rose 7.5% to settle at $9.13 after the company's subsidiary Princess Cruises announced a new summer season of cruises roundtrip from Los Angeles in 2023.
- The Boeing Company (NYSE:BA) gained 7.4% to close at $147.15. The company announced Q2 deliveries, including June deliveries of 51. The company also announced it delivered 216 jets in the first half of 2021.
- Hawaiian Holdings, Inc. (NASDAQ:HA) gained 6.5% to close at $15.05. Susquehanna maintained Hawaiian Holdings with a Neutral and lowered the price target from $17 to $16.
- Cosmos Holdings Inc. (NASDAQ:COSM) gained 6.4% to close at $0.4452. Cosmos Holdings said its subsidiary, Decahedron Ltd., has been granted full membership to the PAGB, a UK-based consumer healthcare association.
- Delta Air Lines, Inc. (NYSE:DAL) rose 6.2% to settle at $31.09. Susquehanna maintained Delta Air Lines with a Positive and lowered the price target from $47 to $35.
- Novo Integrated Sciences, Inc. (NASDAQ:NVOS) rose 5.8% to close at $2.00. The company said it sees Q3 preliminary unaudited revenue to be in the range of $13.4 million to $13.9 million, a surge of around 463% to 484% year-over-year.
